FDA Approves First-of-Its-Kind Eye Drops for Presbyopia
2025-08-07
LENZ Therapeutics' VIZZ, an aceclidine-based eye drop, has received FDA approval for the treatment of presbyopia. This innovative treatment shrinks the pupil, creating a 'pinhole effect' that improves near vision for up to 10 hours without significantly affecting distance vision or causing side effects like those seen with previous treatments. Expected to launch in Q4 2025, VIZZ offers a groundbreaking solution for the millions suffering from age-related blurry near vision.